PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 10362188-1 1999 OBJECTIVES: This study examined the effect of a small-molecule, direct thrombin inhibitor, argatroban, on reperfusion induced by tissue plasminogen activator (TPA) in patients with acute myocardial infarction (AMI). argatroban 91-101 chromosome 20 open reading frame 181 Homo sapiens 129-157 10362188-1 1999 OBJECTIVES: This study examined the effect of a small-molecule, direct thrombin inhibitor, argatroban, on reperfusion induced by tissue plasminogen activator (TPA) in patients with acute myocardial infarction (AMI). argatroban 91-101 chromosome 20 open reading frame 181 Homo sapiens 159-162 10362188-3 1999 In vitro and in vivo studies have shown that argatroban has advantages over heparin for the inhibition of clot-bound thrombin and for the enhancement of thrombolysis with TPA. argatroban 45-55 chromosome 20 open reading frame 181 Homo sapiens 171-174 28754831-0 2017 Letter by Shah Regarding Article, "Randomized, Multicenter Trial of ARTSS-2 (Argatroban With Recombinant Tissue Plasminogen Activator for Acute Stroke)". argatroban 77-87 chromosome 20 open reading frame 181 Homo sapiens 105-133 10751791-0 1998 Comparison of Argatroban and Hirudin for the Reperfusion of Thrombotic Arterial Occlusion by Tissue Plasminogen Activator. argatroban 14-24 chromosome 20 open reading frame 181 Homo sapiens 93-121